H3 K27m-mutant Glioma
📧 Sign up to get email alerts when something new happens for H3 K27m-mutant Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas [Phase 1]
A Phase I multicenter peptide vaccine trial named MultIceNTER for newly diagnosed H3 K27M-mutant glioma is active but not recruiting, sponso…